Biologics Safety Testing Market

Key Players in the Biologics Safety Testing are Focusing on Acquisition and Expansions

The biologics safety testing market is expected to reach USD 4.90 Billion by 2022 from USD 2.75 Billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Growth in pharmaceutical and biotechnology industry driven by government support in both industries, the positive trend of R&D investment in the life sciences industry and an increase in the number of new drug launches are the major factors driving the growth of this market.

Acquisition and expansion are the main strategies followed by key players in the biologics safety testing market. Leading players that adopted this strategy include Lonza Group LTD. (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany), SGS SA (Switzerland), WuXi Apptec (China), Thermo Fisher Scientific Inc. (U.S.), and Sartorius AG (Germany).

Merck KGaA (Germany) is a key player in the biologics safety testing market. The company focuses on acquisitions of other companies which provide safety testing products and services in the market. This strategy allows the company to increase its sales as well as to strengthen its position in the biologics safety testing market. For instance, in 2015, the company acquired Sigma-Aldrich Corporation (U.S.).

Lonza Group LTD. (Switzerland) is an important player in the biologics safety testing market. The company mainly focuses on product launches and expansions to strengthen its position in the market. For instance in 2016, the company opened a laboratory in Switzerland.

SGS SA (Switzerland) is another leading player in the market. The company adopted organic strategies for growth in the market such as expansions. In 2015, the company opened its testing facility in U.S. this facility provides microbiological testing, raw material testing, and stability testing for its customers. The same year the company also opened quality control laboratory in France.

Related Reports:

Biologics Safety Testing Market by Product (Instruments, Services, Kits & Reagents), Test (Endotoxin, Sterility Test, Cell Line Authentication, Bioburden), Application (Vaccine Development, Blood Products, Stem Cell Research) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Report Code
BT 3334
RI Published ON
7/19/2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biologics Safety Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved